However, no differences in FcγRI (CD64), FcγRII (CD32), or FcγRIIIa (CD16) expression were observed in the cancer cell–conditioned macrophages, indicating that they have the potential to respond to antibody stimulation (Fig. 7G). The gene discussed is FCGR2B; the disease is cancer.